Research & Development: Page 91
-
PharmaVoice Team/PharmaVoice
Table of Contents
On the Cover The age of personalized medicine The study of genomics holds promise for helping to identify better drug targets and guiding companies in designing trials. The hope is that pharmacogenomics will lead to more targeted therapies. Features Patient recruitment marketing Patient recruitme...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Is there anything more personal than healthcare? Whether we are talking about medical records or medicine — personalization is coming into vogue, albeit with a caveat on privacy protection. According to a recent Wall Street Journal Online/Harris Interactive Health-Care poll, when it comes to the ...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
PharmaTrax
PharmaTrax Sales, Marketing, and R&D Trends from Industry Analysts Scientific Expertise and Good Value Are Important When Choosing a CRO The primary factors pharmaceutical and biotechnology companies consider when selecting a CRO are the strength of its scientific expertise and the cost/value...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by James Rogers Merging Clinical-Trials Safety and Pharmacovigilance The Winds of change in safety monitoring In November 2003, Mark B. McClellan, M.D., Ph.D., a former commissioner with the Food and Drug Administration, made the comment: “…there is no such thing as a completely safe ...
By James Rogers • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Registering Safety
By Kim Ribbink As the emphasis on drug development shifts toward improving risk management, new tools have emerged to evaluate safety both pre- and postapproval. Increasingly, companies are looking at patient registries as an integral part of their safety arsenal. Drug safety has become the focal...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Already 2007 is shaping up to be an interesting time. A new Congress, shifting demographics, regulatory restrictions, and other factors are sure to keep industry leaders on their toes. In early December, Pfizer’s two big announcements made headlines: first, a major reduction in its salesforce, th...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Phase Forward Expands Clinical-Trials Signal Detection System Phase Forward has unveiled a new version (2.0) of its clinical trials signal detection system — CTSD. The CTSD system enables clinical safety and medical monitoring sta...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
January 16-17 Pharma Pricing Strategies Radisson SAS, Rome For more information, contact Martin Manik, Jacob Fleming Group, at 42-12-5825-2729, e-mail [email protected], or visit jacobfleming.com. January 16-18 Pharmaceutical Leaders’ Summit Delray Beach Marriott, Delray Beach, Fla. F...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Is EDC the next CDMS?
VIEW on Data Management Is EDC the next CDMS? The lines between EDC and CDMS continue to blur as technology catches up with practicality and the need for cleaner data faster. Glen de Vries Glen de Vries, Cofounder and Chief Technology Officer of Medidata Solutions Worldwide, discusses why EDC is ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
EDC VS. CDM -- Choosing A Data-Collection Model
Conducting clinical trials is a highly specialized business that requires highly specific supporting software. The combination of complex functional and technical requirements, along with stringent regulatory requirements, means that standard cross-industry applications are rarely adequate. data ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
November 15 Turn Market Research into a Competitive Advantage McCann Erickson Building, New York For more information, contact Laura DeGroot, Healthcare Marketing & Communications Council, at 610-868-8299, e-mail [email protected], or visit hmc-council.org. November 15-16 International Pa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Addressing the Silo Mentality
The industry is made up of hundreds of companies, public and private, large and small, some with highly developed R&D and commercial capabilities, and some with little more than two brilliant scientists and a molecule. cross-functional communications Anyone who works in the pharmaceutical and...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Winds of Change Continue for the CME Community
medical education The updated criteria for CME means there will be an increased emphasis on measuring the outcomes of education. In recent years, the CME community has demonstrated the ability to manage complex change in the processes related to seeking funding, as well as assuring independence a...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Patient Recruitment
An emerging trend among pharmaceutical and biotechnology companies is more up-front planning and budgeting for patient recruitment. According to David Fox, president and CEO of Praxis, this is a trend that will continue in 2007. “The industry is under increasing pressure to streamline the drug-de...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
Sales Training Consultancy Formed New consultancy launched to improve pharmaceutical training success. For pharmaceutical training professionals struggling to wade through the array of vendor pitches for products and services, Impactiviti LLC, led by industry veteran Steve Woodruff, founder, cons...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
BBK Launches E-Business Suite of Tools for Patient Recruitment Pharmaceutical, medical-device, and biotechnology companies can now take advantage of BBK Worldwide’s TCN e-Systems, a licensable e-business patient-recruitment solutions offering. With TCN e-Systems, study sponsors have greater contr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor -- A Year in Preview
As another year comes to a close, it’s natural to stop and take stock of the events that have shaped the industry and to look ahead in anticipation of what’s next on the horizon. Once again, PharmaVOICE appreciates the time that so many industry executives took out of their busy schedules to comm...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Investigator Training
Year in Preview 12 Ways to Improve Training for Clinical Studies training for clinical studies Investigator meetings are, in fact, training sessions. But there is a tremendous gap between current prevailing practices and best practices in preparing study sites to conduct individual clinical trial...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Year in Preview Then & Now Thought leaders review their 2005 predictions for 2006. The Discovery process Balancing scientific breakthroughs with ethical and safety issues. investigator training Best practices for preparing study sites for clinical trials. A new paradigm for clinical developme...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Discovery Process
Year in Preview Human embryonic stem cells (hESC), proteomics, molecular profiling, and other cutting-edge technologies are generating excitement in the lab as scientists continue to balance scientific breakthroughs with ethical and safety development issues. scientific breakthroughs Before a dru...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Year in Preview -- Featured Thought Leaders
Year in Preview Thought leaders Indexed by Section What the Future Holds Richard Gliklich, M.D., President and CEO, Outcome Simon S. Higginbotham, VP and Chief Marketing Officer, Kendle Ravi Kiron, Ph.D., MBA, Pharma/Biotech Strategy Executive, Formerly Alza Corp. John Potthoff, Ph.D., Chief Oper...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Year in Preview -- Featured Thought Leaders
Thought leaders Indexed by Company Affiliation Adair-Greene Healthcare Communications Mark S. Perlotto Advanced Cell Technology Inc. William M. Caldwell IV Advanstar Communications Inc. Andrew Weissberg Advaxis Inc. John Rothman, Ph.D. Aerovance Inc. William J. Newell, J.D. Ariad Pharmaceuticals ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Crystal Ball
What the Future Holds As PharmaVOICE presents its third annual Year in Preview issue, we asked our readers to look forward and provide us with their insights on the hot issues, topics, and trends that they think will impact the life-sciences/pharmaceutical industry in 2007. This is their chance t...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Adaptive Clinical Trials Technology is the Driving Force
Adaptive Clinical Trials Technology is the Driving Force Richard Piazza, MS, Pharm.D., VP, Product Strategy October 2006 VIEW on E-Solutions Modern medicine is headed down a path of rapid growth and development and increased efficiency. The FDA and the industry as a whole are looking ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
E-solutions have come a long way, but life-sciences companies are still taking baby steps compared with other industries. Good or bad, regulatory restrictions, particularly regarding privacy and security issues, are holding companies back. The industry, however, is working through these issues. ...
By PharmaVoice Team • Jan. 2, 2008
Previous
